Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, ...
An abundance of unskilled and illiterate workers may significant challenges for the rapidly evolving mechanised farms ...